315 related articles for article (PubMed ID: 19075706)
1. Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.
Hirohata M; Ono K; Yamada M
Curr Pharm Des; 2008; 14(30):3280-94. PubMed ID: 19075706
[TBL] [Abstract][Full Text] [Related]
2. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a "protein misfolding disease".
De Lorenzi E; Giorgetti S; Grossi S; Merlini G; Caccialanza G; Bellotti V
Curr Med Chem; 2004 Apr; 11(8):1065-84. PubMed ID: 15078166
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Hirohata M; Ono K; Naiki H; Yamada M
Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
7. Drug Insight: emerging therapies for amyloidosis.
Gillmore JD; Hawkins PN
Nat Clin Pract Nephrol; 2006 May; 2(5):263-70. PubMed ID: 16932439
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
9. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies.
Azam F; Alabdullah NH; Ehmedat HM; Abulifa AR; Taban I; Upadhyayula S
J Biomol Struct Dyn; 2018 Jun; 36(8):2099-2117. PubMed ID: 28571516
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Hirohata M; Ono K; Morinaga A; Yamada M
Neuropharmacology; 2008 Mar; 54(3):620-7. PubMed ID: 18164319
[TBL] [Abstract][Full Text] [Related]
11. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
[TBL] [Abstract][Full Text] [Related]
12. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Gasparini L; Ongini E; Wilcock D; Morgan D
Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
[TBL] [Abstract][Full Text] [Related]
13. [The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease].
Cakała M; Strosznajder JB
Neurol Neurochir Pol; 2010; 44(1):65-79. PubMed ID: 20358486
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs for the chemoprevention of Alzheimer's disease.
Szekely CA; Town T; Zandi PP
Subcell Biochem; 2007; 42():229-48. PubMed ID: 17612054
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease.
Heneka MT; Kummer MP; Weggen S; Bulic B; Multhaup G; Münter L; Hüll M; Pflanzner T; Pietrzik CU
Curr Alzheimer Res; 2011 Mar; 8(2):115-31. PubMed ID: 21345168
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.
Cole GM; Frautschy SA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):140-8. PubMed ID: 20205646
[TBL] [Abstract][Full Text] [Related]
17. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal Anti-inflammatory Drugs as Candidates for the Prevention or Treatment of Alzheimer's Disease: Do they Still Have a Role?
Villarejo-Galende A; González-Sánchez M; Blanco-Palmero VA; Llamas-Velasco S; Benito-León J
Curr Alzheimer Res; 2020; 17(11):1013-1022. PubMed ID: 33245273
[TBL] [Abstract][Full Text] [Related]
19. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.
Agdeppa ED; Kepe V; Petri A; Satyamurthy N; Liu J; Huang SC; Small GW; Cole GM; Barrio JR
Neuroscience; 2003; 117(3):723-30. PubMed ID: 12617976
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and Alzheimer's disease.
Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
